Lexicon Pharmaceuticals, Inc. (LXRX)
1.63
-0.05
(-2.98%)
USD |
NASDAQ |
Mar 26, 12:10
Lexicon Pharmaceuticals Cash from Investing (Quarterly) : 4.83M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Viemed Healthcare, Inc. | -7.612M |
| ANI Pharmaceuticals, Inc. | -1.403M |
| Novavax, Inc. | 20.48M |
| Kura Oncology, Inc. | -64.60M |
| Liquidia Corp. | -4.038M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -17.23M |
| Cash from Financing (Quarterly) | -2.927M |
| Free Cash Flow | -67.85M |
| Free Cash Flow Per Share (Quarterly) | -0.0474 |
| Free Cash Flow to Equity (Quarterly) | -14.52M |
| Free Cash Flow to Firm (Quarterly) | -15.20M |
| Free Cash Flow Yield | -11.46% |